Found 26 articles for: "seborrheic keratosis"
Assessing Patients’ Satisfaction With Hydrogen Peroxide Topical Solution, 40% for Treatment of Raised Seborrheic Keratoses
December 2020 | Volume 19 | Issue 12 | Original Article | 1184 | Copyright © December 2020
Objectives: Assess participants’ satisfaction following treatment with a proprietary hydrogen peroxide topical solution 40%, w/w (HP40) for raised seborrheic keratoses (SKs).
Utilization of an Online Cash-Pay Pharmacy for Topical 5-Fluorouracil Prescriptions in Older Patients
May 2020 | Volume 19 | Issue 5 | Original Article | 539 | Copyright © May 2020
Background: High cost of prescription medications presents a challenging issue for older patients with multimorbidities. Topical 5-fluorouracil (5-FU) is an effective treatment for ac...
Successful Treatment of Porokeratosis With Ablative Fractional Carbon Dioxide Laser and Vitamin C, E, and Ferulic Acid Serum
November 2019 | Volume 18 | Issue 11 | Case Reports | 1174 | Copyright © November 2019
Porokeratosis is a rare disorder of epidermal keratinization that encompasses several clinical forms, characterized by erythematous, annular plaques with an atrophic center and hyperkeratotic ridge-li...
July 2019 | Volume 18 | Issue 7 | Supplement Individual Articles | 178 | Copyright © July 2019
Seborrheic keratosis (SK) is an extremely common benign cutaneous lesion that often appears on individuals older than the age of 50. SK lesions can appear in numerous clinical variations...
Clinical Experience With 40% Hydrogen Peroxide Topical Solution for the Treatment of Seborrheic Keratosis
July 2019 | Volume 18 | Issue 7 | Supplement Individual Articles | 173 | Copyright © July 2019
Despite reassurances about the benign nature of seborrheic keratoses (SKs), patients often request treatment due to cosmetic concerns or for symptomatic relief when SKs become irritated ...
ESKATA (hydrogen peroxide) Topical Solution 40% (w/w) for the Treatment of Raised Seborrheic Keratoses
July 2019 | Volume 18 | Issue 7 | Supplement Individual Articles | 172 | Copyright © July 2019
“Barnacles”, “liverspots”, “age spots": Seborrheic keratoses (SKs) have many different names, sizes, and clinical presentations in our patients. The only co...
July 2019 | Volume 18 | Issue 7 | Original Article | 633 | Copyright © July 2019
Background: As facial aesthetic procedures have become more widely accepted, the racial and ethnic diversity of aesthetic patient populations has increased. Asian Americ...
Anatomic Site–Specific Treatment Response With 40% Hydrogen Peroxide (w/w) Topical Formulation for Raised Seborrheic Keratoses: Pooled Analysis of Data from Two Phase 3 Studies
October 2018 | Volume 17 | Issue 10 | Original Article | 1092 | Copyright © October 2018
OBJECTIVE: Seborrheic keratoses (SKs) may present in any non-glabrous skin, but data are limited on the response to treatment as based on the SK location. We aimed to understand the relationship betwe...
October 2018 | Volume 17 | Issue 10 | Original Article | 1032 | Copyright © October 2018
BACKGROUND: Epidemiologic studies of patients who present to dermatology clinics are necessary to identify the needs of patients. OBJECTIVE: To quantify and compare diagnoses according to race, eth...
September 2018 | Volume 17 | Issue 9 | Original Article | 933 | Copyright © September 2018
Seborrheic keratosis (SK) is the most common skin tumor seen by dermatologists in everyday practice. Although the lesions are mostly benign, many patients still elect to have asymptomatic SK removed. ...
April 2018 | Volume 17 | Issue 4 | Case Reports | 471 | Copyright © April 2018
A 50-year-old African-American woman presented to the dermatology clinic with a pruritic eruption of 3 years’ duration. On clinical examination, the patient had well-demarcated, pink, atrophic plaqu...
November 2017 | Volume 16 | Issue 11 | Original Article | 1064 | Copyright © November 2017
The seborrheic keratosis is the most common benign skin tumor of middle-aged and elderly adults, affecting nearly 83 million individuals in the US alone. Although these are benign lesions, many pat...
September 2017 | Volume 16 | Issue 9 | Original Article | 835 | Copyright © September 2017
Seborrheic keratosis (SK) is a benign epidermal keratinocytic tumor that is extremely common, particularly in individuals over the age of 50. Most individuals with SK will have more than one lesion...
June 2017 | Volume 16 | Issue 6 | Supplement Individual Articles | 98 | Copyright © June 2017
INTRODUCTION: Looking at alternatives to standard injectables and devices for rejuvenation, typical indications for facial rejuvenation are poor skin quality, pigmentary changes, and the loss of sh...
June 2017 | Volume 16 | Issue 6 | Supplement Individual Articles | 77 | Copyright © June 2017
Aging is a complex process influenced by both extrinsic and intrinsic factors. Premature signs of aging due to cumulative UV exposure represent a major concern of the cosmetic patient. Skin of colo...
May 2017 | Volume 16 | Issue 5 | Original Article | 419 | Copyright © May 2017
The seborrheic keratosis, which is ubiquitous throughout all populations, is a benign tumor of the skin. Seborrheic keratosis are among the top 20 dermatologic conditions treated by dermatologists....
October 2016 | Volume 15 | Issue 10 | Case Reports | 1267 | Copyright © October 2016
OBJECTIVE: To describe a case in which a patient developed Candida esophagitis (CE) after treatment of atopic dermatitis (AD) with mycophenolate mofetil (MMF) for 22 months. CASE SUMMARY: A 59-year-o...
April 2016 | Volume 15 | Issue 4 | Original Article | 496 | Copyright © April 2016
There are few creams that have been developed for the purpose of treating the aging hand, yet UV damage and secondary signs of aging on the hands make them one of the most obvious indicators of age ou...
Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management
October 2015 | Volume 14 | Issue 10 | Original Article | 1119 | Copyright © October 2015
Seborrheic keratosis (SK) is among the most common cutaneous lesions, affecting some 83 million Americans. Biologically benign, SK lesions do not require removal for medical reasons unless histologic ...
Systematic Review of Vismodegib Toxicity Profile in the Treatment of Advanced Basal Cell Carcinomas Compared to Other Systemic Therapies in Dermatology
June 2014 | Volume 13 | Issue 6 | Original Article | 729 | Copyright © June 2014
Vismodegib is a first-in-class, hedgehog-signal inhibitor that is FDA-approved for use with advanced basal cell carcinomas (BCCs) that cannot be removed by either surgical resection or treated with ra...
Media and other results for: "seborrheic keratosis"
No results found